This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Limoneira (LMNR) Q2 Earnings Beat Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 5% and 0.76%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
Hormel Foods (HRL) Beats Q2 Earnings Estimates
by Zacks Equity Research
Hormel (HRL) delivered earnings and revenue surprises of 2.56% and 2.78%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Archer Daniels Midland, Corteva, Adecoagro and Limoneira
by Zacks Equity Research
Archer Daniels Midland, Corteva, Adecoagro and Limoneira have been highlighted in this Industry Outlook article.
4 Agriculture Operations Stocks in Focus Amid Wavering Industry Trends
by Rajani Lohia
Raw material and commodity price inflation, along with tight supply conditions, is expected to mar the Agriculture - Operations industry in the near term. Companies like ADM, CTVA, AGRO and LMNR look poised to gain on solid product portfolios and innovation.
Zacks.com featured highlights include Limoneira, Playa Hotels & Resorts and MINISO Group Holding
by Zacks Equity Research
Limoneira, Playa Hotels & Resorts and MINISO Group Holding are part of the Zacks Screen of the Week article.
3 Top Breakout Stocks Worth Buying for Solid Returns
by Tirthankar Chakraborty
Limoneira Co (LMNR), Playa Hotels & Resorts (PLYA) and MINISO Group Holding Limited (MNSO) have been selected as the breakout stocks for today.
Limoneira (LMNR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -47.22% and 1.01%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Limoneira (LMNR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dole (DOLE) Moves 7.8% Higher: Will This Strength Last?
by Zacks Equity Research
Dole (DOLE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Limoneira (LMNR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -190.91% and 20.34%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Calavo Growers (CVGW) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Calavo (CVGW) delivered earnings and revenue surprises of -91.89% and 20.11%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Apogee (APOG) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Apogee's (APOG) Q3 results will likely reflect the continued strong performance in Architectural Services and Framing Systems, pricing actions, and productivity improvement efforts.
Factors Likely to Influence NIKE's (NKE) Earnings in Q2
by Zacks Equity Research
NIKE's (NKE) Q2 results are likely to reflect gains from strong demand, digital momentum and product innovation, offset by rising costs, higher markdowns and adverse currency effects.
Limoneira (LMNR) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Limoneira (LMNR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors to Note Ahead of BlackBerry's (BB) Q3 Earnings Release
by Zacks Equity Research
BlackBerry's (BB) third-quarter fiscal 2023 revenues are likely to have benefited from billings growth, and higher demand for IoT and cyber-security solutions.
Will Limoneira (LMNR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Limoneira (LMNR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Best Income Stocks to Buy for December 5th
by Zacks Equity Research
LMNR and RPM made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 5, 2022.
New Strong Buy Stocks for December 5th
by Zacks Equity Research
LMNR, CIR, TITN, RPM and SHBI have been added to the Zacks Rank #1 (Strong Buy) List on December 5, 2022.
Can Limoneira (LMNR) Climb 29% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Limoneira (LMNR) points to a 29.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
FEMSA (FMX) to Expand Digital Payments With NetPay Buyout
by Zacks Equity Research
FEMSA (FMX) entered a deal to acquire NetPay to expand its digital payment portfolio, and support micro, small and medium-sized businesses in Mexico.
Wall Street Analysts Predict a 40% Upside in Limoneira (LMNR): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 40% in Limoneira (LMNR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Nu Skin (NUS) Dips on Q3 Earnings & Revenue Miss, View Cut
by Zacks Equity Research
Nu Skin's (NUS) third-quarter 2022 results are hurt by higher-than-anticipated macro headwinds, continued inflation, and unfavorable currency. Management lowers the full-year view.
Newell (NWL) Surpasses Q3 Earnings, Misses Sales Estimates
by Zacks Equity Research
Newell's (NWL) Q3 results reflect the adverse impacts of a tough environment, reduced inventory, inflationary pressures and unfavorable currency. Also, management slashes its 2022 view.
Keurig Dr Pepper (KDP) Q3 Earnings Meet, Sales Lag Estimates
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q3 results gain from a robust performance in its cold beverages, a recovery in the supply chain of coffee and better pricing. KDP retains its view for 2022.
Coca-Cola (KO) Q3 Earnings & Sales Beat Estimates, Stock Rises
by Zacks Equity Research
Coca-Cola's (KO) Q3 results reflect gains from an improved price/mix, increased concentrate sales and volume growth, which has aided organic sales growth across its segments.